Book chapter
Challenges in the Management and Prevention of Japanese Encephalitis
Meningitis and Encephalitis, pp.153-174
Springer International Publishing
07/20/2018
DOI: 10.1007/978-3-319-92678-0_11
Abstract
Japanese encephalitis (JE), a viral disease transmitted by Culex mosquitos, is one of the major global health threats with three billion of the world’s population living in at risk JE-endemic areas. Most JE infections are asymptomatic, but when clinical neuroinvasive disease does ensue, mortality can be as high as 30% with 20–30% permanent morbidity among survivors. The recommended confirmation test is JE IgM in CSF (preferred) or serum with limitations of dengue cross-reactivity and fair sensitivity.
Supportive treatment remains the mainstay of care for symptomatic JE infection. Several therapeutic agents have been explored, but most failed to demonstrate significant benefit. The vaccination, especially for children in endemic areas and for nonimmune travelers, remains the best method to prevent JE along with routine personal protective measures to avoid mosquito bites. The comprehensiveness of JE immunization programs varies greatly, dependent on national policymaking that often does not cover all endemic areas. Moreover, public and physician awareness remains low for JE vaccination in high-risk travelers. Gaps in knowledge, strategies, and resources for JE need to be addressed.
Details
- Title: Subtitle
- Challenges in the Management and Prevention of Japanese Encephalitis
- Creators
- Quanhathai Kaewpoowat - Chiang Mai UniversityLinda Aurpibul - Chiang Mai UniversityRommanee Chaiwarith - Maharaj Nakorn Chiang Mai Hospital
- Resource Type
- Book chapter
- Publication Details
- Meningitis and Encephalitis, pp.153-174
- Publisher
- Springer International Publishing; Cham
- DOI
- 10.1007/978-3-319-92678-0_11
- Language
- English
- Date published
- 07/20/2018
- Academic Unit
- Internal Medicine
- Record Identifier
- 9984363154702771
Metrics
14 Record Views